Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers

Diagnostic Microbiology and Infectious Disease

Volumn 44, Issue 3, 2002, Pages 273-280

  Sader, Helio S ^a   Jones, Ronald N ^b,c   Andrade Baiocchi, Soraya ^a   Biedenbach, Douglas J ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b JMI LABORATORIES   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIINFECTIVE AGENT; CARBAPENEM; CIPROFLOXACIN; MEROPENEM; OXACILLIN; PENICILLIN G; PIPERACILLIN; TAZOBACTAM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM ISOLATE; BLOOD FLOW; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENTEROCOCCUS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; LABORATORY; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SOUTH AND CENTRAL AMERICA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TIME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HOSPITALS; HUMANS; LATIN AMERICA; MICROBIAL SENSITIVITY TESTS; PREVALENCE; SENTINEL SURVEILLANCE;

EID: 0036864706     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00469-8     Document Type: Article

References (18)

1. Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 39:1995;1211-1233.
2. Cormican M.G., Marshall S.A., Jones R.N. Detection of extended-spectrum β-lactamase (ESBL)-producing strains by Etest ESBL screen. J Clin Microbiol. 34:1996;1880-1884.
3. Diekema D.J., Pfaller M.A., Jones R.N., Doern G.V., Kugler K.C., Beach M.L., Sader H.S. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. International Journal of Antimicrobial Agents. 13:2000;257-271.
4. Diekema D.J., Pfaller M.A., Jones R.N., Doern G.V., Winokur P.L., Gales A.C., Sader H.S., Kugler K., Beach M. Survey of bloodstream infections due to gram-negative bacilli Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997 . Clin Infect Dis. 29:1999;595-607.
5. Fung-Tomc J.C., Minassian B., Kolek B., Huczko E., Aleksunes L., Stickle T., Washo T., Gradelski E., Valera L., Bonner D.P. Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756. Antimicrob Agents Chemother. 44:2000;3351-3356.
6. Jones R.N. Important and emerging β-lactamase-mediated resistances in hospital-based pathogens The Amp C enzymes . Diagn Microbiol Infect Dis. 31:1998;461-466.
7. Jones R.N., Pfaller M.A. Bacterial resistance a worldwide problem . Diagn Microbiol Infect Dis. 31:1998;379-388.
8. Jones R.N., Sader H.S., Erwin M.E. Emerging multiply resistant enterococci (MRE) among clinical isolates Prevalence data from 97 medical centers . Diagn Microbiol Infect Dis. 21:1995;85-93.
9. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: fifth edition. Approved document M7-A5. 2000;NCCLS, Wayne, PA.
10. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement M100-S12. 2002;NCCLS, Wayne, PA.
11. Pfaller M.A., Jones R.N., Doern G.V., Sader H.S., Kugler K.C., Beach M.L. Survey of blood stream infections attributable to gram-positive cocci Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program . Diagn Microbiol Infect Dis. 33:1999;283-297.
12. Renaud B., Brun-Buisson C. Outcomes of primary and catheter-related bacteremia a cohort and case-control study in critically ill patients. Am J Respir Crit Care Med. 163:2001;1584-1590.
13. Sader H.S., Gales A.C. Emerging strategies in infectious diseases New carbapenem and trinem antimicrobial agents . Drugs. 61:2001;553-564.
14. Sader H.S., Gales A.C., Pfaller M.A., Mendes R.E., Zoccoli C.M., Barth A., Jones R.N. Pathogen frequency and resistance patterns in Brazilian hospitals Summary of results from three years of the SENTRY antimicrobial surveillance program . Brazilian Journal of Infectious Diseases. 5:2001;200-214.
15. Sader H.S., Jones R.N., Gales A.C., Klugler K., Pfaller M.A., Doern G.V. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia Results from the SENTRY Antimicrobial Surveillance Program (1997) . Diagn Microbiol Infect Dis. 32:1998;289-301.
16. Sader H.S., Pfaller M.A., Jones R.N., Doern G.V., Gales A.C., Winokur P.L., Kugler K.C. Bacterial pathogens isolated from patients with blood stream infections in Latin America, 1997 Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program . Brazilian Journal of Infectious Diseases. 3:1999;97-110.
17. Troillet N., Samore M.H., Carmeli Y. Imipenem-resistant Pseudomonas aeruginosa risk factors and antibiotic susceptibility patterns . Clin Infect Dis. 25:1997;1094-1098.
18. Voss A., Milatovic D., Wallrauch-Schwarz C., Rosdahl V.T., Braveny I. Methicillin resistance in Europe. Eur J Clin Microbiol Infect Dis. 13:1994;50-55.